Skip to main content
Leaving UL Solutions website
Within UL Solutions we provide a broad portfolio of offerings to all the medical device industries. This includes certification, Approved/Notified Body and consultancy services. In order to protect and prevent any conflict of interest, perception of conflict of interest and protection of both our brand and our customers brand, we have processes in place to identify and manage any potential conflicts of interest and maintain impartiality. UL Solutions is unable to provide consultancy services to EU MDD, MDR or IVDD Notified Body, UKCA MD Approved Body or MDSAP Customers.
  • On-demand Webinar

Changes to Prop 65 and Five Substances Restricted Under TSCA

Understand upcoming changes to Prop 65 and five new substances restricted under TSCA.

Woman scanning a label at the grocery store

California Proposition 65 (Prop 65) is the most heavily enforced restricted materials legislation in the world, with over 300 prosecutions per month. Prosecutions have been avoidable by providing generic warnings on packaging. Under the proposed amendments, this will no longer be possible.  

At the federal level, under the new rules published by the EPA in January 2021, five substances will now be banned in articles. 

Learning objectives:

This webinar describes the restrictions, deadlines, common uses of the chemicals, and practical approaches to compliance, considering the short deadlines involved.

Speaker:

Bruce Calder, vice president of regulatory, Claigan

Webinar date:

March 17, 2021

Watch the on-demand webinar

Understanding Updates and Compliance Requirements to Prop 65

Performance Testing for Consumer Products

Leveraging UL’s performance testing services, you can communicate safety, quality and durability through your product’s performance claims.

Learn more